Cargando…
Mortality after percutaneous coronary revascularization: Prior cardiovascular risk factor control and improved outcomes in patients with diabetes mellitus
OBJECTIVES: To assess the mortality in patients with diabetes mellitus (DM) following percutaneous coronary intervention (PCI) according to their insulin requirement and PCI setting (elective, urgent, and emergency). BACKGROUND: DM is a major risk factor to develop coronary artery disease (CAD). It...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5484298/ https://www.ncbi.nlm.nih.gov/pubmed/28029209 http://dx.doi.org/10.1002/ccd.26882 |
_version_ | 1783245858565783552 |
---|---|
author | Noman, Awsan Balasubramaniam, Karthik Alhous, M. Hafez A. Lee, Kelvin Jesudason, Peter Rashid, Muhammad Mamas, Mamas A. Zaman, Azfar G. |
author_facet | Noman, Awsan Balasubramaniam, Karthik Alhous, M. Hafez A. Lee, Kelvin Jesudason, Peter Rashid, Muhammad Mamas, Mamas A. Zaman, Azfar G. |
author_sort | Noman, Awsan |
collection | PubMed |
description | OBJECTIVES: To assess the mortality in patients with diabetes mellitus (DM) following percutaneous coronary intervention (PCI) according to their insulin requirement and PCI setting (elective, urgent, and emergency). BACKGROUND: DM is a major risk factor to develop coronary artery disease (CAD). It is unclear if meticulous glycemic control and aggressive risk factor management in patients with DM has improved outcomes following PCI. METHODS: Retrospective analysis of prospectively collected data on 9,224 patients treated with PCI at a regional tertiary center between 2008 and 2011. RESULTS: About 7,652 patients were nondiabetics (non‐DM), 1,116 had non‐insulin treated diabetes mellitus (NITDM) and 456 had ITDM. Multi‐vessel coronary artery disease, renal impairment and non‐coronary vascular disease were more prevalent in DM patients. Overall 30‐day mortality rate was 2.4%. In a logistic regression model, the adjusted odds ratios (95% confidence intervals [CI]) for 30‐day mortality were 1.28 (0.81–2.03, P = 0.34) in NITDM and 2.82 (1.61–4.94, P < 0.001) in ITDM compared with non‐DM. During a median follow‐up period of 641 days, longer‐term post‐30 day mortality rate was 5.3%. In the Cox's proportional hazard model, the hazard ratios (95% CI) for longer‐term mortality were 1.15 (0.88–1.49, P = 0.31) in NITDM and 1.88 (1.38–2.55, P < 0.001) in ITDM compared with non‐DM group. Similar result was observed in all three different PCI settings. CONCLUSION: In the modern era of aggressive cardiovascular risk factor control in diabetes, this study reveals higher mortality only in insulin‐treated diabetic patients following PCI for stable coronary artery disease and acute coronary syndrome. Importantly, diabetic patients with good risk factor control and managed on diet or oral hypoglycemics have similar outcomes to the non‐diabetic population. © 2016 The Authors Catheterization and Cardiovascular Interventions Published by Wiley Periodicals, Inc. |
format | Online Article Text |
id | pubmed-5484298 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-54842982017-07-10 Mortality after percutaneous coronary revascularization: Prior cardiovascular risk factor control and improved outcomes in patients with diabetes mellitus Noman, Awsan Balasubramaniam, Karthik Alhous, M. Hafez A. Lee, Kelvin Jesudason, Peter Rashid, Muhammad Mamas, Mamas A. Zaman, Azfar G. Catheter Cardiovasc Interv Coronary Artery Disease OBJECTIVES: To assess the mortality in patients with diabetes mellitus (DM) following percutaneous coronary intervention (PCI) according to their insulin requirement and PCI setting (elective, urgent, and emergency). BACKGROUND: DM is a major risk factor to develop coronary artery disease (CAD). It is unclear if meticulous glycemic control and aggressive risk factor management in patients with DM has improved outcomes following PCI. METHODS: Retrospective analysis of prospectively collected data on 9,224 patients treated with PCI at a regional tertiary center between 2008 and 2011. RESULTS: About 7,652 patients were nondiabetics (non‐DM), 1,116 had non‐insulin treated diabetes mellitus (NITDM) and 456 had ITDM. Multi‐vessel coronary artery disease, renal impairment and non‐coronary vascular disease were more prevalent in DM patients. Overall 30‐day mortality rate was 2.4%. In a logistic regression model, the adjusted odds ratios (95% confidence intervals [CI]) for 30‐day mortality were 1.28 (0.81–2.03, P = 0.34) in NITDM and 2.82 (1.61–4.94, P < 0.001) in ITDM compared with non‐DM. During a median follow‐up period of 641 days, longer‐term post‐30 day mortality rate was 5.3%. In the Cox's proportional hazard model, the hazard ratios (95% CI) for longer‐term mortality were 1.15 (0.88–1.49, P = 0.31) in NITDM and 1.88 (1.38–2.55, P < 0.001) in ITDM compared with non‐DM group. Similar result was observed in all three different PCI settings. CONCLUSION: In the modern era of aggressive cardiovascular risk factor control in diabetes, this study reveals higher mortality only in insulin‐treated diabetic patients following PCI for stable coronary artery disease and acute coronary syndrome. Importantly, diabetic patients with good risk factor control and managed on diet or oral hypoglycemics have similar outcomes to the non‐diabetic population. © 2016 The Authors Catheterization and Cardiovascular Interventions Published by Wiley Periodicals, Inc. John Wiley and Sons Inc. 2016-12-28 2017-06-01 /pmc/articles/PMC5484298/ /pubmed/28029209 http://dx.doi.org/10.1002/ccd.26882 Text en © 2016 The Authors Catheterization and Cardiovascular Interventions Published by Wiley Periodicals, Inc. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Coronary Artery Disease Noman, Awsan Balasubramaniam, Karthik Alhous, M. Hafez A. Lee, Kelvin Jesudason, Peter Rashid, Muhammad Mamas, Mamas A. Zaman, Azfar G. Mortality after percutaneous coronary revascularization: Prior cardiovascular risk factor control and improved outcomes in patients with diabetes mellitus |
title | Mortality after percutaneous coronary revascularization: Prior cardiovascular risk factor control and improved outcomes in patients with diabetes mellitus |
title_full | Mortality after percutaneous coronary revascularization: Prior cardiovascular risk factor control and improved outcomes in patients with diabetes mellitus |
title_fullStr | Mortality after percutaneous coronary revascularization: Prior cardiovascular risk factor control and improved outcomes in patients with diabetes mellitus |
title_full_unstemmed | Mortality after percutaneous coronary revascularization: Prior cardiovascular risk factor control and improved outcomes in patients with diabetes mellitus |
title_short | Mortality after percutaneous coronary revascularization: Prior cardiovascular risk factor control and improved outcomes in patients with diabetes mellitus |
title_sort | mortality after percutaneous coronary revascularization: prior cardiovascular risk factor control and improved outcomes in patients with diabetes mellitus |
topic | Coronary Artery Disease |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5484298/ https://www.ncbi.nlm.nih.gov/pubmed/28029209 http://dx.doi.org/10.1002/ccd.26882 |
work_keys_str_mv | AT nomanawsan mortalityafterpercutaneouscoronaryrevascularizationpriorcardiovascularriskfactorcontrolandimprovedoutcomesinpatientswithdiabetesmellitus AT balasubramaniamkarthik mortalityafterpercutaneouscoronaryrevascularizationpriorcardiovascularriskfactorcontrolandimprovedoutcomesinpatientswithdiabetesmellitus AT alhousmhafeza mortalityafterpercutaneouscoronaryrevascularizationpriorcardiovascularriskfactorcontrolandimprovedoutcomesinpatientswithdiabetesmellitus AT leekelvin mortalityafterpercutaneouscoronaryrevascularizationpriorcardiovascularriskfactorcontrolandimprovedoutcomesinpatientswithdiabetesmellitus AT jesudasonpeter mortalityafterpercutaneouscoronaryrevascularizationpriorcardiovascularriskfactorcontrolandimprovedoutcomesinpatientswithdiabetesmellitus AT rashidmuhammad mortalityafterpercutaneouscoronaryrevascularizationpriorcardiovascularriskfactorcontrolandimprovedoutcomesinpatientswithdiabetesmellitus AT mamasmamasa mortalityafterpercutaneouscoronaryrevascularizationpriorcardiovascularriskfactorcontrolandimprovedoutcomesinpatientswithdiabetesmellitus AT zamanazfarg mortalityafterpercutaneouscoronaryrevascularizationpriorcardiovascularriskfactorcontrolandimprovedoutcomesinpatientswithdiabetesmellitus |